John M. Evans, CEO at Beam Therapeutics Inc. (BEAM), sold 95,000 shares at $85.19 ($8.0M) on 2021-10-06, disclosed to the SEC on 2021-10-08.
Open-market sale of $8.0M BEAM by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.71 | 2,171 | $180K | 2.3% |
| 2 | $82.71 | 2,171 | $180K | 2.3% |
| 3 | $82.72 | 3,149 | $260K | 3.3% |
| 4 | $82.72 | 3,149 | $260K | 3.3% |
| 5 | $83.47 | 13,406 | $1.1M | 14.1% |
| 6 | $83.47 | 13,406 |
| $1.1M |
| 14.1% |
| 7 | $83.49 | 9,863 | $823K | 10.3% |
| 8 | $83.49 | 9,863 | $823K | 10.3% |
| 9 | $84.45 | 7,566 | $639K | 8.0% |
| 10 | $84.45 | 7,566 | $639K | 8.0% |
| 11 | $84.45 | 10,444 | $882K | 11.1% |
| 12 | $84.45 | 10,444 | $882K | 11.1% |
| 13 | $85.19 | 701 | $60K | 0.8% |
| 14 | $85.19 | 701 | $60K | 0.8% |
| 15 | $85.24 | 400 | $34K | 0.4% |
| Total | $83.79 avg | 95,000 | $8.0M | 100% |
| Filing → |
| BEAM | SELL | 2026-04-01 | $1.1M | — | Filing → |
| BEAM | SELL | 2026-02-02 | $2.8M | — | Filing → |
| BEAM | SELL | 2025-10-03 | $1.2M | — | Filing → |